BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190318
DTEND;VALUE=DATE:20190320
DTSTAMP:20190307T225112Z
CREATED:20181223T215408Z
LAST-MODIFIED:20190307T225112Z
UID:20616-1552867200-1553039999@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs 2019
DESCRIPTION:SMi Group’s Annual Superbugs & Superdrugs conference will take place 18-19 March\, 2019 in London\, UK. \nThis year’s event will gather leaders from pharmaceutical companies\, academia and the wider scientific community together with regulatory agencies and public-private partnerships\, to discuss the growing threat of antibiotic resistance. \nHighlighted session topics and focus areas include: \n\nDevelopment of a pipeline of lysins for infections caused by multidrug-resistant gram-negative bacteria\nAnti-infective research: funding\, filing and finance\nDeveloping target product profiles for priority pathogens\nHow to mobilize private investors for antibiotic drug development\nWellcome Trust: funding opportunities for anti-infective research\nConsiderations for beta-lactams paired with beta-lactamase inhibitors\nA unique combination antibiotic therapy at Helperby\nRidinilazole for the treatment of C. difficile\nDeveloping new therapies for fungal infection\nPharmacodynamics to accelerate antimicrobial drug development for AMR\nOpportunities and challenges involved in pre-clinical development of novel immunotherapies\nEvaluations in prophylaxis and treatment murine models of pneumocystis pneumonia\n\nTo register visit www.superbugssuperdrugs.com/globalbiodefence \nGlobal Biodefense in an official media partner of Superbugs & Superdrugs 2019.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Rd\, London\, SW7 4DN\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2018/11/superbugs-2019-london.jpg
END:VEVENT
END:VCALENDAR